deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 8-arm NCT01410942

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

Sponsor: American Cancer Society, Inc.

Conditions Prostate Cancer
Interventions Cognitive Behavioral Therapy (CBT) Counseling Sessions Methylphenidate Placebo Sham Exercise Standardized Exercise Intervention Program
Updated 19 times since 2017 Last updated: Feb 18, 2026 Started: Feb 8, 2012 Primary completion: Sep 30, 2026 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Prostate Cancer and is currently ongoing. American Cancer Society, Inc. leads this study, which shows 19 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Jul 2020 · 13 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshot~Jul 2022 – ~Apr 2023 · 9 months · monthly snapshot~Apr 2023 – ~Oct 2023 · 6 months · monthly snapshot~Oct 2023 – ~Feb 2024 · 4 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

19 versions recorded

  1. Feb 2026 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2025 — Feb 2026 [monthly]

    Active Not Recruiting PHASE2

  3. Mar 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

  4. Feb 2025 — Mar 2025 [monthly]

    Active Not Recruiting PHASE2

  5. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting PHASE2

▶ Show 14 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Oct 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE2

  5. Jul 2022 — Apr 2023 [monthly]

    Active Not Recruiting PHASE2

  6. Dec 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE2

  7. Jan 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE2

  8. Jul 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  9. Jun 2019 — Jul 2020 [monthly]

    Active Not Recruiting PHASE2

  10. Apr 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE2

  11. Jun 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE2

  12. Mar 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  13. Feb 2017 — Mar 2018 [monthly]

    Active Not Recruiting PHASE2

  14. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American Cancer Society, Inc.
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations